Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis.
Dager
William E
WE
D058186:Acute Kidney Injury / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007362:Intensive Care Units; D007677:Kidney Function Tests; D008297:Male; D000077731:Meropenem; D006435:Renal Dialysis / Q000379:methods*; D018570:Risk Assessment; D013845:Thienamycins / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016896:Treatment Outcome; D014640:Vancomycin / Q000493:pharmacokinetics* / Q000627:therapeutic use
D013845:Thienamycins; D014640:Vancomycin; D000077731:Meropenem